Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Guest

Showing results (221-230 of 492) with videos related to

Pageof 50
Sort By:
Spinal Cord|December 21, 2006
Guidelines for the conduct of clinical trials for spinal cord injury (SCI) as developed by the ICCP panel: clinical trial outcome measuresJ D Steeves, D Lammertse, A Curt, et al.
Spinal Cord|December 21, 2006
Guidelines for the conduct of clinical trials for spinal cord injury as developed by the ICCP panel: spontaneous recovery after spinal cord injury and statistical power needed for therapeutic clinical trialsJ W Fawcett, A Curt, J D Steeves, et al.
Journal of Neurotrauma|March 24, 2021
Phase 1 Safety Trial of Autologous Human Schwann Cell Transplantation in Chronic Spinal Cord InjuryKatie L Gant, James D Guest, Anne E Palermo, et al.
Gastroenterology|October 16, 2021
An Antigenically Diverse, Representative Panel of Envelope Glycoproteins for Hepatitis C Virus Vaccine DevelopmentJordan H Salas, Richard A Urbanowicz, Johnathan D Guest, et al.
BMJ Open|July 18, 2023
Secondary analysis of a James Lind Alliance priority setting partnership to facilitate knowledge translation in degenerative cervical myelopathy (DCM): insights from AO Spine RECODE-DCMBenjamin Davies, Jamie Brannigan, Oliver D Mowforth, et al.
Global Spine Journal|February 17, 2022
Degenerative Cervical Myelopathy: Development and Natural History [AO Spine RECODE-DCM Research Priority Number 2]Aria Nouri, Enrico Tessitore, Granit Molliqaj, et al.
Journal of Neurosurgery. Spine|September 19, 2012
Predictors of pulmonary complications in blunt traumatic spinal cord injuryBizhan Aarabi, James S Harrop, Charles H Tator, et al.
Nature Communications|April 8, 2024
Author Correction: Molecular and phenotypic characteristics of RSV infections in infants during two nirsevimab randomized clinical trialsBahar Ahani, Kevin M Tuffy, Anastasia A Aksyuk, et al.
Nature Communications|July 19, 2023
Molecular and phenotypic characteristics of RSV infections in infants during two nirsevimab randomized clinical trialsBahar Ahani, Kevin M Tuffy, Anastasia A Aksyuk, et al.
Neurobiology of Disease|May 15, 2021
Elezanumab, a human anti-RGMa monoclonal antibody, promotes neuroprotection, neuroplasticity, and neurorecovery following a thoracic hemicompression spinal cord injury in non-human primatesPeer B Jacobson, Robin Goody, Matthew Lawrence, et al.
Pageof 50

Showing results (221-230 of 492) with videos related to

Sort By:
Pageof 50
Spinal Cord|December 21, 2006
Guidelines for the conduct of clinical trials for spinal cord injury (SCI) as developed by the ICCP panel: clinical trial outcome measuresJ D Steeves, D Lammertse, A Curt, et al.
Spinal Cord|December 21, 2006
Guidelines for the conduct of clinical trials for spinal cord injury as developed by the ICCP panel: spontaneous recovery after spinal cord injury and statistical power needed for therapeutic clinical trialsJ W Fawcett, A Curt, J D Steeves, et al.
Journal of Neurotrauma|March 24, 2021
Phase 1 Safety Trial of Autologous Human Schwann Cell Transplantation in Chronic Spinal Cord InjuryKatie L Gant, James D Guest, Anne E Palermo, et al.
Gastroenterology|October 16, 2021
An Antigenically Diverse, Representative Panel of Envelope Glycoproteins for Hepatitis C Virus Vaccine DevelopmentJordan H Salas, Richard A Urbanowicz, Johnathan D Guest, et al.
BMJ Open|July 18, 2023
Secondary analysis of a James Lind Alliance priority setting partnership to facilitate knowledge translation in degenerative cervical myelopathy (DCM): insights from AO Spine RECODE-DCMBenjamin Davies, Jamie Brannigan, Oliver D Mowforth, et al.
Global Spine Journal|February 17, 2022
Degenerative Cervical Myelopathy: Development and Natural History [AO Spine RECODE-DCM Research Priority Number 2]Aria Nouri, Enrico Tessitore, Granit Molliqaj, et al.
Journal of Neurosurgery. Spine|September 19, 2012
Predictors of pulmonary complications in blunt traumatic spinal cord injuryBizhan Aarabi, James S Harrop, Charles H Tator, et al.
Nature Communications|April 8, 2024
Author Correction: Molecular and phenotypic characteristics of RSV infections in infants during two nirsevimab randomized clinical trialsBahar Ahani, Kevin M Tuffy, Anastasia A Aksyuk, et al.
Nature Communications|July 19, 2023
Molecular and phenotypic characteristics of RSV infections in infants during two nirsevimab randomized clinical trialsBahar Ahani, Kevin M Tuffy, Anastasia A Aksyuk, et al.
Neurobiology of Disease|May 15, 2021
Elezanumab, a human anti-RGMa monoclonal antibody, promotes neuroprotection, neuroplasticity, and neurorecovery following a thoracic hemicompression spinal cord injury in non-human primatesPeer B Jacobson, Robin Goody, Matthew Lawrence, et al.
Pageof 50